We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$1.15B
AUM Growth
+$59M
Cap. Flow
-$87.2M
Cap. Flow %
-7.58%
Top 10 Hldgs %
12.78%
Holding
1,132
New
384
Increased
172
Reduced
194
Closed
306

Top Buys

Rank Stock Value
1
CEF icon
Sprott Physical Gold and Silver Trust
CEF
+$12.8M
2
JIH.U
Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00
JIH.U
+$9.53M
3
ZAGG
ZAGG Inc Common Stock (Delaware)
ZAGG
+$8.79M
4
AMZN icon
Amazon
AMZN
+$6.74M
5
BABA icon
Alibaba
BABA
+$6.59M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$15.9M
2
CELG
Celgene Corp
CELG
+$15M
3
AABA
Altaba Inc
AABA
+$10.1M
4
BMTX
BM Technologies, Inc.
BMTX
+$9.25M
5
GCMG icon
GCM Grosvenor
GCMG
+$8.1M

Sector Composition

Rank Sector Weight
1 Technology 13.52%
2 Healthcare 10.04%
3 Consumer Discretionary 6.7%
4 Real Estate 4.77%
5 Communication Services 4.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VBIV
1026
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
– –
-3,333
Closed -$47K
AFT
1027
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
– –
-12,800
Closed -$190K
DMTK
1028
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-15,000
Closed -$84K
CPE
1029
DELISTED
Callon Petroleum Company
CPE
– –
-147,312
Closed -$6.39M
CBAY
1030
DELISTED
Cymabay Therapeutics
CBAY
– –
-26,790
Closed -$137K
NEPT
1031
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
– –
-87
Closed -$433K
BFX
1032
DELISTED
BowFlex Inc.
BFX
– –
-17,125
Closed -$23K
ORTX
1033
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-5,080
Closed -$604K
VMW
1034
DELISTED
VMware, Inc
VMW
– –
-3,544
Closed -$532K
CCF
1035
DELISTED
Chase Corporation
CCF
– –
-2,127
Closed -$233K
RAD
1036
DELISTED
Rite Aid Corporation
RAD
– –
-12,700
Closed -$88K
RETA
1037
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-87
Closed -$699K
RETA
1038
PUT
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-59
Closed -$474K
BKI
1039
CALL
DELISTED
Black Knight, Inc. Common Stock
BKI
– –
-202
Closed -$1.23M
ISEE
1040
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-93,533
Closed -$105K
ATCX
1041
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
– –
-14,699
Closed -$148K
AGRX
1042
DELISTED
Agile Therapeutics
AGRX
– –
-18
Closed -$42K
MYOV
1043
DELISTED
Myovant Sciences Ltd.
MYOV
– –
-19,725
Closed -$103K
VVNT
1044
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
– –
-31,000
Closed -$320K
AVYA
1045
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
– –
-28,493
Closed -$291K
TCDA
1046
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-14,283
Closed -$441K
THCA
1047
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
– –
-575,000
Closed -$5.64M
CCXI
1048
CALL
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-417
Closed -$283K
ACC
1049
DELISTED
American Campus Communities, Inc.
ACC
– –
-10,397
Closed -$500K
SRRA
1050
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
– –
-3,034
Closed -$47K
40 41
42
43 44

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return

Boothbay Fund Management's Q4 2019 Portfolio in Review

As of Q4 2019, Boothbay Fund Management held 1,132 positions worth $1.15B, up 5.4% from $1.09B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boothbay Fund Management withdrew a net $87.2M in Q4 2019, closing 306 positions and reducing 194 holdings. Its most notable exit was Celgene Corp, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Boothbay Fund Management opened a new position in Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00 worth $9.4M.

  • Boothbay Fund Management's largest Q4 2019 buy was Juniper Industrial Holdings, Inc. Units, each consisting of one share of Class A common stock, $0.00: 949,000 shares worth $9.4M.
  • Boothbay Fund Management added most to Sprott Physical Gold and Silver Trust in Q4 2019, an estimated $12.8M increase.
  • Boothbay Fund Management's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $15.9M.
  • Boothbay Fund Management fully exited Celgene Corp in Q4 2019, selling an estimated $15M.
  • Boothbay Fund Management's ten largest holdings make up 13% of its $1.15B portfolio in Q4 2019.
  • Boothbay Fund Management opened 384 new positions and closed 306 in Q4 2019.
  • Boothbay Fund Management's portfolio value rose 5.4% quarter-over-quarter to $1.15B.

Based on Boothbay Fund Management's 13F filing for Q4 2019, filed 14 Feb 2020.